CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 7 filers reported holding CRISPR THERAPEUTICS AG in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $25,418 | -19.3% | 560 | -0.2% | 0.00% | -50.0% |
Q2 2023 | $31,495 | +238.0% | 561 | +172.3% | 0.00% | +100.0% |
Q1 2023 | $9,317 | +11.3% | 206 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $8,374 | -76.1% | 206 | -61.9% | 0.00% | -50.0% |
Q3 2022 | $35,000 | -51.4% | 541 | -52.2% | 0.00% | -50.0% |
Q2 2022 | $72,000 | +1.4% | 1,131 | -0.6% | 0.00% | +33.3% |
Q1 2022 | $71,000 | -47.4% | 1,138 | -36.1% | 0.00% | -40.0% |
Q4 2021 | $135,000 | -31.1% | 1,782 | +0.8% | 0.01% | -37.5% |
Q3 2021 | $196,000 | -28.7% | 1,767 | +0.1% | 0.01% | -27.3% |
Q2 2021 | $275,000 | +23.3% | 1,766 | +3.8% | 0.01% | +83.3% |
Q1 2021 | $223,000 | +14.9% | 1,701 | 0.0% | 0.01% | -25.0% |
Q4 2020 | $194,000 | +106.4% | 1,701 | +51.7% | 0.01% | +60.0% |
Q3 2020 | $94,000 | +14.6% | 1,121 | 0.0% | 0.01% | 0.0% |
Q2 2020 | $82,000 | +173.3% | 1,121 | +55.5% | 0.01% | +150.0% |
Q1 2020 | $30,000 | -58.9% | 721 | -35.7% | 0.00% | -50.0% |
Q4 2019 | $73,000 | +69.8% | 1,121 | +9.8% | 0.00% | +33.3% |
Q3 2019 | $43,000 | -10.4% | 1,021 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $48,000 | +33.3% | 1,021 | 0.0% | 0.00% | +50.0% |
Q1 2019 | $36,000 | +33.3% | 1,021 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $27,000 | +237.5% | 1,021 | +410.5% | 0.00% | +100.0% |
Q3 2018 | $8,000 | -68.0% | 200 | -63.5% | 0.00% | -50.0% |
Q1 2018 | $25,000 | – | 548 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |